Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/6560
Title: Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Authors: BOCCI, VELIO
Zanardi, Iacopo
VALACCHI, GIUSEPPE
BORRELLI, EMMA
Travagli, Valter 
Issue Date: 2015
Project: None 
Journal: CARDIOVASCULAR & HAEMATOLOGICAL DISORDERS - DRUG TARGETS
Abstract: 
The state-of-the-art of oxygen-ozone therapy is now clarified and all the mechanisms of action of medical ozone are within classical biochemistry and molecular biology. The outcomes of standard treatments in peripheral arterial occlusive disease (PAOD) and dry-form of age-related macular degeneration (AMD) have been compared with the documented therapeutic results achieved with ozonated autohemotherapy (O-AHT). On the other hand, the clinical data of O-AHT on stroke remain indicative. As the cost of O-AHT is almost irrelevant, its application in all public hospitals, especially those of poor Countries, would allow two advantages: the first is for the patient, who will improve her/his conditions, and the second is for Health Authorities burdened with increasing costs. The aim of this paper is to report to clinical scientists that O-AHT is a scientific-based therapeutic approach without side effects. The integration of O-AHT with effective approved drugs is likely to yield the best clinical results in several chronic inflammatory diseases.
Description: 
205746
URI: http://hdl.handle.net/20.500.12779/6560
ISSN: 1871-529X
DOI: 10.2174/1871529X1502151209114642
Appears in Collections:Publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.